Assessing the origin of high-grade serous ovarian cancer using CRISPR-modification of mouse organoids

Autor: Harry Begthel, Johan H. van Es, Hans Clevers, Oded Kopper, Celien P.H. Vreuls, Kadi Lõhmussaar, Jeroen Korving
Přispěvatelé: Hubrecht Institute for Developmental Biology and Stem Cell Research
Jazyk: angličtina
Rok vydání: 2020
Předmět:
0301 basic medicine
endocrine system diseases
General Physics and Astronomy
Organ Culture Techniques/methods
Epithelium
Mice
0302 clinical medicine
CRISPR-Associated Protein 9
lcsh:Science
Gene Editing/methods
Gene Editing
Ovarian Neoplasms
Multidisciplinary
biology
BRCA1 Protein
Fallopian Tubes/pathology
CRISPR-Cas Systems/genetics
Ovarian Neoplasms/drug therapy
PTEN Phosphohydrolase/genetics
female genital diseases and pregnancy complications
Organoids
medicine.anatomical_structure
030220 oncology & carcinogenesis
Oviduct
Tumor Suppressor Protein p53/genetics
Female
Antineoplastic Agents/pharmacology
Epithelium/pathology
Organoids/drug effects
endocrine system
Neurofibromatosis 1
Science
Antineoplastic Agents
General Biochemistry
Genetics and Molecular Biology

Neurofibromatosis 1/genetics
Article
03 medical and health sciences
Organ Culture Techniques
Ovarian cancer
medicine
Organoid
PTEN
Animals
Cancer models
Fallopian Tubes
Ovary
PTEN Phosphohydrolase
Cancer
General Chemistry
medicine.disease
Transplantation
030104 developmental biology
Tumor progression
Mutation
Genetic engineering
biology.protein
Cancer research
BRCA1 Protein/genetics
lcsh:Q
Ovary/pathology
CRISPR-Cas Systems
Tumor Suppressor Protein p53
Fallopian tube
Zdroj: Nature Communications, Vol 11, Iss 1, Pp 1-14 (2020)
Nature Communications
Nature Communications, 11(1). Nature Publishing Group
ISSN: 2041-1723
Popis: High-grade serous ovarian cancer (HG-SOC)—often referred to as a “silent killer”—is the most lethal gynecological malignancy. The fallopian tube (murine oviduct) and ovarian surface epithelium (OSE) are considered the main candidate tissues of origin of this cancer. However, the relative contribution of each tissue to HG-SOC is not yet clear. Here, we establish organoid-based tumor progression models of HG-SOC from murine oviductal and OSE tissues. We use CRISPR-Cas9 genome editing to introduce mutations into genes commonly found mutated in HG-SOC, such as Trp53, Brca1, Nf1 and Pten. Our results support the dual origin hypothesis of HG-SOC, as we demonstrate that both epithelia can give rise to ovarian tumors with high-grade pathology. However, the mutated oviductal organoids expand much faster in vitro and more readily form malignant tumors upon transplantation. Furthermore, in vitro drug testing reveals distinct lineage-dependent sensitivities to the common drugs used to treat HG-SOC in patients.
The relative contribution of fallopian tube (FT) or ovarian surface epithelium (OSE) to high-grade serous ovarian cancer (HG-SOC) development is unclear. Here, the authors establish organoid models from murine oviductal and OSE tissues that allow cancer modeling via CRISPR-Cas9 genome editing, and report a dual origin of murine HG-SOC.
Databáze: OpenAIRE